| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 32.601 | 41.066 | 74.637 | 76.758 | 99.619 | 35.760 | 17.134 | 18.333 | 12.724 |
| Total Income - EUR | - | 32.602 | 41.066 | 74.637 | 76.758 | 99.698 | 35.760 | 17.134 | 18.333 | 12.724 |
| Total Expenses - EUR | - | 39.390 | 62.526 | 57.901 | 66.132 | 63.608 | 27.703 | 11.468 | 16.625 | 11.450 |
| Gross Profit/Loss - EUR | - | -6.789 | -21.459 | 16.736 | 10.625 | 36.090 | 8.058 | 5.666 | 1.708 | 1.274 |
| Net Profit/Loss - EUR | - | -7.115 | -21.870 | 15.990 | 9.858 | 35.094 | 7.670 | 5.197 | 1.512 | 896 |
| Employees | - | 4 | 5 | 5 | 4 | 3 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Ixo Labs Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 5.137 | 3.185 | 2.010 | 1.811 | 652 | 509 | 511 | 509 | 507 |
| Current Assets | - | 36.381 | 12.356 | 32.077 | 40.987 | 65.708 | 17.184 | 20.684 | 19.560 | 17.971 |
| Inventories | - | 0 | 0 | 289 | 425 | 862 | 843 | 845 | 843 | 838 |
| Receivables | - | 28.557 | 11.547 | 17.483 | 27.782 | 31.098 | 7.981 | 13.927 | 3.034 | 950 |
| Cash | - | 7.824 | 809 | 14.305 | 12.780 | 33.748 | 8.360 | 5.911 | 15.682 | 16.183 |
| Shareholders Funds | - | -6.892 | -28.646 | -12.130 | -2.038 | 33.095 | 14.495 | 5.401 | 1.715 | 2.602 |
| Social Capital | - | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | 48.410 | 44.187 | 46.218 | 44.835 | 33.266 | 3.198 | 15.794 | 18.354 | 15.876 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Ixo Labs Srl